|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 900 7th Street, NW |
Address2 | Suite 975 |
City | Washington |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Mansfield |
State | MA |
Zip Code | 02048 |
Country | USA |
|
5. Senate ID# 319778-12
|
||||||||
|
6. House ID# 395090000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Susan K. Bunning, Vice President, Government Affairs |
Date | 01/15/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Issues related to controlled substances, pain and addiction drugs generally.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Susan |
Bunning |
|
|
|
Jonathan |
Collard |
|
|
|
Jack |
Kalavritinos |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
As the parent, Covidien Ltd. (as disclosed on the LD1) has an interest in the issues list above.
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 1424 Paul Wellstone Mental Health and Addiction Equity Act, sec 105, provisions related to Medicaid Drug Rebate;
HR 5606 Physicians Payments Sunshine Act of 2008;
S 2029 Physician Payments Sunshine Act of 2007;
HR 6631 Medicare Improvements for Patients and Providers Act;
S 3101 Medicare Improvements for Patients and Providers Act of 2008/S 3118 Preserving Access to Medicare Act 2008
HR 5765 Medicare Remote Monitoring Access Act of 2008;
S 3144/HR 6252, Medicare DMEPOS Competitive Acquisition Reform Act 2008;
S 2221 Transparency in Medical Device Pricing Act;
Issues related to oxygen provisions, competitive bidding and bariatric surgery.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Susan |
Bunning |
|
|
|
Jonathan |
Collard |
|
|
|
Whitney |
Hale |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
As the parent, Covidien Ltd. (as disclosed on the LD1) has an interest in the issues list above.
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 2193 Animal Protection Accountability Improvement Act;
HR 6381 Medical Device Safety Act;
HR 6151 Responsibility in Drug and Device Advertising Act of 2008;
General issues related to healthcare and healthcare reimbursement.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Susan |
Bunning |
|
|
|
Jonathan |
Collard |
|
|
|
Whitney |
Hale |
|
|
|
Jack |
Kalavritinos |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
As the parent, Covidien Ltd. (as disclosed on the LD1) has an interest in the issues list above.
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
HR 6275 Alternative Minimum Tax Relief Act of 2008;
HR 7005 Alternative Minimum Tax Relief Act of 2008;
Administration's Fiscal Year 2009 Budget.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Susan |
Bunning |
|
|
|
Jonathan |
Collard |
|
|
|
Whitney |
Hale |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
As the parent, Covidien Ltd. (as disclosed on the LD1) has an interest in the issues list above.
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY2009 House Financial Services Appropriations;
S 3260 FY09 Senate Financial Services Appropriations;
FY2009 House Defense Appropriations;
FY2009 Senate Defense Appropriations.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Susan |
Bunning |
|
|
|
Jonathan |
Collard |
|
|
|
Whitney |
Hale |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
As the parent, Covidien Ltd. (as disclosed on the LD1) has an interest in the issues list above.
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
HR 1908, S 1145, Patent Reform Act of 2007
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jonathan |
Collard |
|
|
|
Whitney |
Hale |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
As the parent, Covidien Ltd. (as disclosed on the LD1) has an interest in the issues list above.
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |